Search

Your search keyword '"Harald Prüss"' showing total 304 results

Search Constraints

Start Over You searched for: Author "Harald Prüss" Remove constraint Author: "Harald Prüss"
304 results on '"Harald Prüss"'

Search Results

1. Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial

2. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)

3. High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome

4. Brain-targeting autoantibodies in patients with dementia

5. MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review

6. Molecular dissection of an immunodominant epitope in Kv1.2-exclusive autoimmunity

7. Hypertrophic Pachymeningitis with Persistent Intrathecal Inflammation Secondary to Neurosarcoidosis Treated with Intraventricular Chemotherapy: A Case Report

8. Depressive symptoms and anti-N-methyl-D-aspartate-receptor GluN1 antibody seropositivity in the PROSpective cohort with incident stroke

9. Deep clinical phenotyping of patients with obsessive-compulsive disorder: an approach towards detection of organic causes and first results

10. Synapsin autoantibodies during pregnancy are associated with fetal abnormalities

11. Human NMDAR autoantibodies disrupt excitatory-inhibitory balance, leading to hippocampal network hypersynchrony

12. High frequency of cerebrospinal fluid autoantibodies in patients with seizures or epilepsies of unknown etiology

13. Fighting Post-COVID and ME/CFS – development of curative therapies

14. Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology

15. Immunoreactivity to astrocytes in different forms of dementia: High prevalence of autoantibodies to GFAP

16. Monoclonal human auto-antibodies: novel tools for the understanding and treatment of neuropsychiatric symptoms

17. Spectrum of Novel Anti-Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizopheniform and Affective Disorders

18. Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron

19. Rapidly progressive dementia: Extending the spectrum of GFAP‐astrocytopathies?

20. Immunological causes of obsessive-compulsive disorder: is it time for the concept of an 'autoimmune OCD' subtype?

21. Brain blood vessel autoantibodies in patients with NMDA and GABAA receptor encephalitis: identification of unconventional Myosin-X as target antigen

22. Maternal synapsin autoantibodies are associated with neurodevelopmental delay

23. Anti-NMDA Receptor Encephalitis in a Patient with Tuberous Sclerosis-Related Brain Tumor: A Case Report

24. Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis

25. Anti-neuronal antibodies against brainstem antigens are associated with COVID-19

26. Case Report: Possible autoimmune obsessive-compulsive disorder with postpartum onset

27. Antigenic imprinting in SARS‐CoV‐2

28. Sex difference in cerebrospinal fluid/blood albumin quotients in patients with schizophreniform and affective psychosis

29. Brain antibody sequence evaluation (BASE): an easy-to-use software for complete data analysis in single cell immunoglobulin cloning

30. Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis

31. SOP: antibody-associated autoimmune encephalitis

32. Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance

33. A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome — A Report on the Clinical Presentations of the First 100 Patients

34. Potential Cross-Links of Inflammation With Schizophreniform and Affective Symptoms: A Review and Outlook on Autoimmune Encephalitis and COVID-19

35. Novel Antineuronal Autoantibodies With Somatodendritic Staining Pattern in a Patient With Autoimmune Psychosis

36. Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies

37. Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients—Lessons Learned From SARS and MERS

38. Anti-N-Methyl-D-Aspartate-Receptor Encephalitis: A 10-Year Follow-Up

39. Transdiagnostic hippocampal damage patterns in neuroimmunological disorders

40. GABAB receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis

41. Psychiatric Presentation of Anti-NMDA Receptor Encephalitis

42. Linkage Evidence for a Two-Locus Inheritance of LQT-Associated Seizures in a Multigenerational LQT Family With a Novel KCNQ1 Loss-of-Function Mutation

43. Olfactory and Gustatory Dysfunction in Patients With Autoimmune Encephalitis

44. Atypical Autoimmune Encephalitis With Neuropil Antibodies Against a Yet Unknown Epitope

45. Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies

46. Psychiatric Manifestation of Anti-LGI1 Encephalitis

47. Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis

48. Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment

50. Functional autoantibodies in patients with different forms of dementia.

Catalog

Books, media, physical & digital resources